Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Exclusive: OpenEvidence aims to be ‘Disney+’ with new JAMA deal. OpenEvidence this morning announced it has a new multi-year ...

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Lately, Pfizer (NYSE: PFE) ...

You’ve probably used Chat GPT for any number of things, but it isn’t the only AI game in town. There are three other major AI platforms getting a lot of attention.

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

The biopharma company achieved $1 billion in revenue for the first time in its September-ended quarter. More recently, it achieved a more significant milestone when it turned prof ...